Comparison of Diabetes Patients - Care Trajectory Versus Convention
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Follow-up in the Diabetes Care Trajectory, Follow-up in the Diabetes Convention.
- Who it may be relevant to
- Registry conditions: Type 2 Diabetes. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Profile of People with Diabetes Followed Up in the Context of the Care Trajectory Versus the Diabetes Convention
Overview
In Belgium, various structures and reimbursement programs are in place for managing Type 2 Diabetes Mellitus (T2DM). The Diabetes Care Trajectory is primarily utilized for patients who require a maximum of two insulin injections per day. In contrast, patients needing multiple daily insulin injections are managed under a diabetes convention program. The Diabetes Care Trajectory has been operational since 2009. However, unlike patients in the diabetes convention program, where the profile and quality of care are regularly audited, there is limited information available regarding the profile and outcomes of patients within the Care Trajectory. This retrospective study aims to compare the profiles, including complications and quality of care, of T2DM patients across both groups.
Detailed description
This retrospective study will collect data from T2DM patients enrolled in either the Diabetes Care Trajectory or the diabetes convention program. The data gathered will encompass quality of care, clinical status, complications, and metabolic state.
The profiles of these patient populations will be compared cross-sectionally for each year within the study period (2009-2024). Additionally, a longitudinal analysis will be conducted to examine the evolution of these profiles over the entire study period. Data will be extracted from electronic case records maintained at participating sites across Belgium.
Interventions
- Other Follow-up in the Diabetes Care Trajectory
Being followed-up in the Diabetes Care Trajectory in Belgium - Other Follow-up in the Diabetes Convention
Being followed-up in the Diabetes Convention in Belgium
Primary outcome measures
- HbA1c [Time frame: Yearly for the entire study period (2009 - 2024)]
Secondary outcome measures (3)
- Complications of diabetes [Time frame: Yearly for the entire study period (2009 - 2024)]
- Cholesterol profile [Time frame: Yearly for the entire study period (2009 - 2024)]
- Insulin requirements [Time frame: Yearly for the entire study period (2009 - 2024)]
Eligibility criteria
Inclusion criteria
- Followed in one of the NexusHealth hospitals in Belgium: https://www.nexuzhealth.com/en/why-nexuzhealth/patients/affiliated-healthcare-institutions
- Having being diagnosed with type 2 diabetes mellitus
- Followed in the Diabetes Care Trajectory or in the Diabetes Convention (group B) in Belgium Exclusion Criteria: no specific exclusion criteria
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06577584 · S69595